The term “vaccine” was coined by Louis Pasteur and derived from “Vacca”, meaning cow the term devised by Edward Jenner to denote cowpox. A vaccine is defined as a biological preparation that provides active acquired immunity to a particular disease and typically contains an agent that resembles a disease-causing microorganism and is often made from the exhaust or killed forms of the microbe, its toxins, or one of its surface proteins.
Vaccines have two major effects:
a) Vaccines protect individuals against disease.
b) If there are sufficient immune individuals in populations, the transmission of the infection is prevented. This is known as herd immunity.
Vaccine Design mainly includes the Production of vaccines and has several stages.
Firstly, the antigen itself is generated and Viruses are grown either on primary cells such as chicken eggs (e.g., for influenza), or on continuous cell lines such as cultured human cells (e.g., for hepatitis A). Bacteria are grown in bioreactors (e.g., haemophilic influenza type B).
Alternatively, a recombinant protein will be derived from the viruses or bacteria can be generated in yeast, bacteria, or cell cultures.
Strategies in vaccine design include:
Vaccine drug delivery system is the preparations given to patients to evoke immune responses that leading to the production of antibodies or cell-mediated responses that will help in combating infectious agents or non-infectious conditions such as malignancies.
The three categories of Vaccine delivery system include:
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia